US Stock MarketDetailed Quotes

FBLG FibroBiologics

Watchlist
  • 12.180
  • -0.140-1.14%
Close May 31 16:00 ET
398.52MMarket Cap-17677P/E (TTM)

FibroBiologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-109.97%-4.28M
-57.43%-6.4M
-36.49%-1.6M
16.68%-1.14M
-1.63M
-2.04M
-188.37%-4.07M
-1.17M
-1.37M
-1.41M
Net income from continuing operations
-250.31%-8.46M
-221.91%-16.49M
-537.60%-9.72M
-40.33%-2.19M
---2.16M
---2.42M
-223.70%-5.12M
---1.52M
---1.56M
---1.58M
Operating gains losses
----
--72K
--0
--0
--57K
--15K
----
----
----
----
Depreciation and amortization
42.71%137K
364.89%437K
38.30%130K
--112K
--99K
--96K
--94K
--94K
--0
--0
Other non cash items
3,879.49%3.1M
1,780.98%7.32M
5,260.00%7.24M
--0
--3K
--78K
--389K
--135K
--136K
----
Change In working capital
262.40%419K
60.59%493K
253.33%318K
8,500.00%504K
---71K
---258K
78.49%307K
--90K
---6K
--172K
-Change in receivables
--0
----
----
----
----
---275K
----
----
----
----
-Change in prepaid assets
-3,450.00%-710K
-187.50%-7K
-131.03%-9K
170.69%41K
---19K
---20K
121.62%8K
--29K
---58K
---37K
-Change in payables and accrued expense
523.86%1.23M
54.67%812K
3.77%275K
390.54%363K
---23K
--197K
125.32%525K
--265K
--74K
--233K
-Change in other current assets
97.18%-2K
333.33%14K
556.25%105K
977.27%193K
---213K
---71K
75.00%-6K
--16K
---22K
---24K
-Change in other current liabilities
-10.11%-98K
-48.18%-326K
75.91%-53K
---93K
---91K
---89K
---220K
---220K
--0
--0
Cash from discontinued investing activities
Operating cash flow
-109.97%-4.28M
-57.43%-6.4M
-36.49%-1.6M
16.68%-1.14M
---1.63M
---2.04M
-188.37%-4.07M
---1.17M
---1.37M
---1.41M
Investing cash flow
Cash flow from continuing investing activities
85.71%-8K
-495K
-2K
-413K
-24K
-56K
0
0
0
Net PPE purchase and sale
85.71%-8K
---495K
---2K
---413K
---24K
---56K
--0
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
85.71%-8K
---495K
---2K
---413K
---24K
---56K
--0
--0
--0
----
Financing cash flow
Cash flow from continuing financing activities
-77.50%3.28M
132.79%13.79M
0
413.33%940K
-1.71M
14.57M
226.09%5.93M
2.15M
-300K
1.82M
Net issuance payments of debt
--459K
-92.05%300K
--0
--0
--300K
--0
147.54%3.78M
--0
---300K
--1.53M
Net common stock issuance
--2.82M
----
----
----
----
--0
----
----
----
----
Net preferred stock issuance
--0
650.60%16.14M
--0
--940K
--10.31M
--4.89M
--2.15M
--2.15M
--0
--0
Proceeds from stock option exercised by employees
--0
----
----
----
----
--10M
----
----
----
----
Net other financing activities
----
---2.65M
--0
--0
---2.32M
---323K
----
----
----
--292K
Cash from discontinued financing activities
Financing cash flow
-77.50%3.28M
132.79%13.79M
--0
413.33%940K
---1.71M
--14.57M
226.09%5.93M
--2.15M
---300K
--1.82M
Net cash flow
Beginning cash position
304.37%9.16M
456.76%2.27M
735.22%10.77M
284.91%11.38M
--14.74M
--2.27M
--407K
--1.29M
--2.96M
--0
Current changes in cash
-108.06%-1.01M
271.01%6.9M
-264.07%-1.6M
63.29%-612K
---3.36M
--12.47M
356.76%1.86M
--977K
---1.67M
--407K
End cash Position
-44.65%8.16M
304.37%9.16M
304.37%9.16M
735.22%10.77M
--11.38M
--14.74M
456.76%2.27M
--2.27M
--1.29M
--407K
Free cash flow
-104.73%-4.28M
-69.60%-6.9M
-36.66%-1.6M
-13.53%-1.55M
---1.65M
---2.09M
-188.37%-4.07M
---1.17M
---1.37M
---1.41M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -109.97%-4.28M-57.43%-6.4M-36.49%-1.6M16.68%-1.14M-1.63M-2.04M-188.37%-4.07M-1.17M-1.37M-1.41M
Net income from continuing operations -250.31%-8.46M-221.91%-16.49M-537.60%-9.72M-40.33%-2.19M---2.16M---2.42M-223.70%-5.12M---1.52M---1.56M---1.58M
Operating gains losses ------72K--0--0--57K--15K----------------
Depreciation and amortization 42.71%137K364.89%437K38.30%130K--112K--99K--96K--94K--94K--0--0
Other non cash items 3,879.49%3.1M1,780.98%7.32M5,260.00%7.24M--0--3K--78K--389K--135K--136K----
Change In working capital 262.40%419K60.59%493K253.33%318K8,500.00%504K---71K---258K78.49%307K--90K---6K--172K
-Change in receivables --0-------------------275K----------------
-Change in prepaid assets -3,450.00%-710K-187.50%-7K-131.03%-9K170.69%41K---19K---20K121.62%8K--29K---58K---37K
-Change in payables and accrued expense 523.86%1.23M54.67%812K3.77%275K390.54%363K---23K--197K125.32%525K--265K--74K--233K
-Change in other current assets 97.18%-2K333.33%14K556.25%105K977.27%193K---213K---71K75.00%-6K--16K---22K---24K
-Change in other current liabilities -10.11%-98K-48.18%-326K75.91%-53K---93K---91K---89K---220K---220K--0--0
Cash from discontinued investing activities
Operating cash flow -109.97%-4.28M-57.43%-6.4M-36.49%-1.6M16.68%-1.14M---1.63M---2.04M-188.37%-4.07M---1.17M---1.37M---1.41M
Investing cash flow
Cash flow from continuing investing activities 85.71%-8K-495K-2K-413K-24K-56K000
Net PPE purchase and sale 85.71%-8K---495K---2K---413K---24K---56K--0--0--0----
Cash from discontinued investing activities
Investing cash flow 85.71%-8K---495K---2K---413K---24K---56K--0--0--0----
Financing cash flow
Cash flow from continuing financing activities -77.50%3.28M132.79%13.79M0413.33%940K-1.71M14.57M226.09%5.93M2.15M-300K1.82M
Net issuance payments of debt --459K-92.05%300K--0--0--300K--0147.54%3.78M--0---300K--1.53M
Net common stock issuance --2.82M------------------0----------------
Net preferred stock issuance --0650.60%16.14M--0--940K--10.31M--4.89M--2.15M--2.15M--0--0
Proceeds from stock option exercised by employees --0------------------10M----------------
Net other financing activities -------2.65M--0--0---2.32M---323K--------------292K
Cash from discontinued financing activities
Financing cash flow -77.50%3.28M132.79%13.79M--0413.33%940K---1.71M--14.57M226.09%5.93M--2.15M---300K--1.82M
Net cash flow
Beginning cash position 304.37%9.16M456.76%2.27M735.22%10.77M284.91%11.38M--14.74M--2.27M--407K--1.29M--2.96M--0
Current changes in cash -108.06%-1.01M271.01%6.9M-264.07%-1.6M63.29%-612K---3.36M--12.47M356.76%1.86M--977K---1.67M--407K
End cash Position -44.65%8.16M304.37%9.16M304.37%9.16M735.22%10.77M--11.38M--14.74M456.76%2.27M--2.27M--1.29M--407K
Free cash flow -104.73%-4.28M-69.60%-6.9M-36.66%-1.6M-13.53%-1.55M---1.65M---2.09M-188.37%-4.07M---1.17M---1.37M---1.41M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Recent IPOs
Recent IPOs
Intraday+0.26%